Global Argatroban Market Data Survey Report 2025

July 2017 | 62 pages | ID: G3195C6AC9FEN
HeyReport

Abstracts

Summary

Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.

The global Argatroban market will reach xxx Million USD in 2017 with CAGR xx% from 2018-2025. The main contents of the report including:

Global market size and forecast

Regional market size, production data and export & import

Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)

Average market price by SUK

Major applications

Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:

• Pfizer
• SANDOZ
• GlaxoSmithKline
• fresenius-kabi
• Eagle Pharmaceuticals
• Mitsubishi Tanabe Pharma
• Teva Pharmaceutical Industries
• WEST-WARD

Major applications as follows:

• Heparin-induced thrombocytopenia (HIT)
• Percutaneous Coronary Intervention
• Cerebral arterial thrombosis

Regional market size, production data and export & import:

• Asia-Pacific
• North America
• Europe
• South America
• Middle East & Africa

Contents

1 GLOBAL MARKET OVERVIEW

1.1 Scope of Statistics
  1.1.1 Scope of Products
  1.1.2 Scope of Manufacturers
  1.1.3 Scope of Application
  1.1.4 Scope of Regions/Countries
1.2 Global Market Size

2 REGIONAL MARKET

2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade

3 KEY MANUFACTURERS

3.1 Pfizer
  3.1.2 Company Information
  3.1.2 Product Specifications
  3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 SANDOZ
  3.2.1 Company Information
  3.2.2 Product Specifications
  3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 GlaxoSmithKline
  3.3.1 Company Information
  3.3.2 Product Specifications
  3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 fresenius-kabi
  3.4.1 Company Information
  3.4.2 Product Specifications
  3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 Eagle Pharmaceuticals
  3.5.1 Company Information
  3.5.2 Product Specifications
  3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 Mitsubishi Tanabe Pharma
  3.6.1 Company Information
  3.6.2 Product Specifications
  3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Teva Pharmaceutical Industries
  3.7.1 Company Information
  3.7.2 Product Specifications
  3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 WEST-WARD
  3.8.1 Company Information
  3.8.2 Product Specifications
  3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

4 MAJOR APPLICATION

4.1 Heparin-induced thrombocytopenia (HIT)
  4.1.1 Overview
  4.1.2 Heparin-induced thrombocytopenia (HIT) Market Size and Forecast
4.2 Percutaneous Coronary Intervention
  4.2.1 Overview
  4.2.2 Percutaneous Coronary Intervention Market Size and Forecast
4.3 Cerebral arterial thrombosis
  4.3.1 Overview
  4.3.2 Cerebral arterial thrombosis Market Size and Forecast

5 MARKET PRICE

5.1 Overview
5.2 Price by SUK

6 CONCLUSION

List Of Tables

LIST OF TABLES

Tab REGIONAL PRODUCTION 2011-2017 (VALUE)
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Value)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Value)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Value)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Value)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of Pfizer
Tab Sales Revenue, Volume, Price, Cost and Margin of SANDOZ
Tab Sales Revenue, Volume, Price, Cost and Margin of GlaxoSmithKline
Tab Sales Revenue, Volume, Price, Cost and Margin of fresenius-kabi
Tab Sales Revenue, Volume, Price, Cost and Margin of Eagle Pharmaceuticals
Tab Sales Revenue, Volume, Price, Cost and Margin of Mitsubishi Tanabe Pharma
Tab Sales Revenue, Volume, Price, Cost and Margin of Teva Pharmaceutical Industries
Tab Sales Revenue, Volume, Price, Cost and Margin of WEST-WARD
Tab Market Price by Region
Tab Market Price by Manufacturers
Tab Market Price by Application
Tab Price by SUK (Popular Goods on the Market)

List Of Figures

LIST OF FIGURES

Fig Global Argatroban Market Size and CAGR 2011-2017 (Value)
Fig Global Argatroban Market Size and CAGR 2011-2017 (Volume)
Fig Global Argatroban Market Forecast and CAGR 2018-2025 (Value)
Fig Global Argatroban Market Forecast and CAGR 2018-2025 (Volume)
Fig Heparin-induced thrombocytopenia (HIT) Market Size and CAGR 2011-2017 (Value)
Fig Heparin-induced thrombocytopenia (HIT) Market Size and CAGR 2011-2017 (Volume)
Fig Heparin-induced thrombocytopenia (HIT) Market Forecast and CAGR 2018-2025 (Value)
Fig Heparin-induced thrombocytopenia (HIT) Market Forecast and CAGR 2018-2025 (Volume)
Fig Percutaneous Coronary Intervention Market Size and CAGR 2011-2017 (Value)
Fig Percutaneous Coronary Intervention Market Size and CAGR 2011-2017 (Volume)
Fig Percutaneous Coronary Intervention Market Forecast and CAGR 2018-2025 (Value)
Fig Percutaneous Coronary Intervention Market Forecast and CAGR 2018-2025 (Volume)
Fig Cerebral arterial thrombosis Market Size and CAGR 2011-2017 (Value)
Fig Cerebral arterial thrombosis Market Size and CAGR 2011-2017 (Volume)
Fig Cerebral arterial thrombosis Market Forecast and CAGR 2018-2025 (Value)
Fig Cerebral arterial thrombosis Market Forecast and CAGR 2018-2025 (Volume)
Fig Global Market Price 2011-2017
Fig Global Market Price 2018-2025